Publication: 2060

Publication: 2060

Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Br J Clin Pharmacol vol 78 (5) 1005-13

Year:: 2014
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:: Xiaofeng Wang was also supported in part by a University of Iowa Presidential Fellowship.

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:

Parents:: 1005
Children:: None

Program:: TRP
Primary Committee:: PPP
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, CA33601, CA41287, CA03927, U10 CA180821, CA16450, CA77440, CA04326, U10 CA180882, U24 CA196171, CA47642, CA31946

Corr. Author:
Authors:: Xiaofeng Wang Kouros Owzar Pankaj Gupta Richard A Larson Flora Mulkey Antonius A Miller Lionel D Lewis David Hurd Ravi Vij Mark J Ratain Daryl J Murry

Networks:

Study: CALGB-10105
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: autoinduction, population pharmacokinetic model, time-dependent clearance, vatalanib